Reports Q4 revenue $430M, consensus $379.42M. “2024 marked the completion of a multi-year effort to transition the business into a highly ...

Avadel Pharmaceuticals' stock is undervalued due to peak sales potential, along with the possibility of a buyout. Click here ...

A study by Griffith University reveals that post-Covid memory issues and concentration problems might be linked to swelling in the hippocampus, simila ...

Since launching in 2017, Plymouth Meeting’s Harmony Biosciences has grown from a small drug developer into a billion-dollar company, writes John ...

Like millions of other Americans, Kelsey Hameister's mood is impacted by the change of seasons. Two in every five say their ...

Deutsche Bank (ETR:DBKGn) initiated coverage on Alkermes (NASDAQ:ALKS) shares with a Buy rating and a price target of $40.00.

Equities research analysts at Roth Capital issued their FY2029 earnings per share estimates for Zevra Therapeutics in a note issued to investors on Sunday, February 9th. Roth Capital analyst J.

Beyond analysts' top -and-bottom-line estimates for Alkermes (ALKS), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the ...

Our picks of the movies you need to be watching on Netflix in February.

The following is a letter that ASL Strategic Value Fund sent to the Board of Directors of Avadel Pharmaceuticals : Mr. Geoff Glass Chairman, Board of Directors Avadel Pharmaceuticals Plc 16640 ...

What once was the Kitten Bowl has evolved into a romper room for kittens, dogs, and puppies, spotlighting the importance of shelter pet adoption. The tussling may be less dramatic, but they’re a ...